First Time Loading...

Organogenesis Holdings Inc
NASDAQ:ORGO

Watchlist Manager
Organogenesis Holdings Inc Logo
Organogenesis Holdings Inc
NASDAQ:ORGO
Watchlist
Price: 2.72 USD -3.55%
Updated: May 23, 2024

Organogenesis Holdings Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Organogenesis Holdings Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Organogenesis Holdings Inc
NASDAQ:ORGO
Revenue
$435.4m
CAGR 3-Years
5%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Revenue
$54.4B
CAGR 3-Years
3%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.5B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Revenue
$29.5B
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$10.2B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
26%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
13%
CAGR 5-Years
15%
CAGR 10-Years
19%

Organogenesis Holdings Inc
Revenue Breakdown

Breakdown by Geography
Organogenesis Holdings Inc

Not Available

Breakdown by Segments
Organogenesis Holdings Inc

Total Revenue: 433.1m USD
100%
Advanced Wound Care: 405.5m USD
93.6%
Surgical And Sports Medicine: 27.6m USD
6.4%

See Also

What is Organogenesis Holdings Inc's Revenue?
Revenue
435.4m USD

Based on the financial report for Mar 31, 2024, Organogenesis Holdings Inc's Revenue amounts to 435.4m USD.

What is Organogenesis Holdings Inc's Revenue growth rate?
Revenue CAGR 5Y
12%

Over the last year, the Revenue growth was -6%. The average annual Revenue growth rates for Organogenesis Holdings Inc have been 5% over the past three years , 12% over the past five years .